Discover
APVO
Aptevo Therapeutics Inc.
1.84
2 x 1.28
2 x 2.24
bid
ask
+
0.00
0.00%
2 @ 07:42 PM
1.89 +0.05 (2.72%)
| Ytd | -80.49% | |
| 1y | -94.84% |
1.82
day range
1.89
1.71
52 week range
35.64
| Open | 1.84 | Prev Close | 1.84 | Low | 1.82 | High | 1.89 | Mkt Cap | 3.33M |
| Vol | 41.30K | Avg Vol | 113.30K | EPS | 456.62 | P/E | 0.00 | Forward P/E | -0.83 |
| Beta | 5.07 | Short Ratio | 0.47 | Inst. Own | 11.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 3.26 | 200-d Avg | 6.60 | 1yr Est | 21.00 |
| Income Statement | |||
| Operating Expenses | 6.44M | ||
| Research and Development Expense | 3.70M | ||
| Selling, General and Administrative Expense | 2.75M | ||
| Operating Income | -6.44M | ||
| Net Income | -6.36M | ||
| Net Income Common Stock | -6.36M | ||
| Net Income Common Stock (USD) | -6.36M | ||
| Consolidated Income | -6.36M | ||
| Earnings per Basic Share | -5.31 | ||
| Earnings per Basic Share (USD) | -5.31 | ||
| Earnings per Diluted Share | -5.31 | ||
| Earning Before Interest & Taxes (EBIT) | -6.36M | ||
| Earning Before Interest & Taxes (USD) | -6.36M | ||
| Weighted Average Shares | 1.20M | ||
| Weighted Average Shares Diluted | 1.20M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.80M | ||
| Cash and Equivalents (USD) | 9.80M | ||
| Current Assets | 10.80M | ||
| Property, Plant & Equipment Net | 3.72M | ||
| Total Assets | 14.52M | ||
| Debt Current | 919.00K | ||
| Total Debt | 4.21M | ||
| Current Liabilities | 5.19M | ||
| Debt Non-Current | 3.29M | ||
| Total Liabilities | 8.48M | ||
| Accumulated Retained Earnings (Deficit) | -288.26M | ||
| Shareholders Equity | 6.04M | ||
| Shareholders Equity (USD) | 6.04M | ||
| Assets Non-Current | 3.72M | ||
| Total Debt (USD) | 4.21M | ||
| Liabilities Non-Current | 3.29M | ||
| Trade and Non-Trade Payables | 1.16M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 302.00K | ||
| Net Cash Flow from Financing | 726.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.73M | ||
| Issuance (Purchase) of Equity Shares | 726.00K | ||
| Net Cash Flow from Operations | -5.45M | ||
| Share Based Compensation | 58.00K | ||